Securities code: 000710 securities abbreviation: Berry Genomics Co.Ltd(000710) Announcement No.: 2022-008 Berry Genomics Co.Ltd(000710)
The chairman and general manager of the company shall act as the chief financial officer of the company, and
Announcement on the appointment of the Secretary of the board of directors of the company
The company and all members of the board of directors guarantee that the information disclosed is true, accurate and complete without false records, misleading statements or major omissions.
The board of directors of Berry Genomics Co.Ltd(000710) (hereinafter referred to as “the company”) recently received the resignation report of Mr. Jin Jin, chief financial officer and Secretary of the board of directors of the company. Mr. Jin Jin applied for resignation from the position of chief financial officer and Secretary of the board of directors for personal reasons. After resignation, he will no longer hold any position in the company.
The 15th meeting of the 9th board of directors of the company deliberated and approved the proposal on the chairman and general manager of the company acting as the chief financial officer of the company and the proposal on the appointment of the Secretary of the board of directors of the company, and agreed that Mr. Gao Yang, chairman and general manager of the company, should act as the chief financial officer of the company and perform the duties of the chief financial officer Ms. AI Wenlu, the investor relations manager of the company, served as the Secretary of the board of directors of the company and performed the duties of secretary of the board of directors. The term of office was from the date of deliberation and approval of the board of directors to the date of expiration of the ninth board of directors. The nomination committee reviewed the qualifications of Mr. Gao Yang and Ms. AI Wenlu (see Annex for resume).
As of the date of this announcement, Mr. Gao Yang directly holds 40310572 shares of the company, accounting for 11.37% of the total share capital of the company. Ms. Hou Ying, director and deputy general manager of the company, is the person acting in concert with Mr. Gao Yang. Ms. Hou Ying directly holds 23355661 shares of the company, accounting for 6.59% of the total share capital of the company. Mr. Gao Yang and Ms. Hou Ying jointly hold 63666233 shares of the company, Accounting for 17.96% of the total share capital of the company. Mr. Jin Jin and Ms. AI Wenlu do not directly hold shares of the company.
The independent directors of the company checked the reasons for Mr. Jin Jin’s resignation from the position of chief financial officer and Secretary of the board of directors, and believed that the reasons for his resignation were consistent with the actual situation and had no significant adverse impact on the actual operation of the company. The independent directors expressed their independent opinions on the proposal on the chairman and general manager of the company acting as the chief financial officer of the company and the proposal on the appointment of the Secretary of the board of directors of the company. For details, please refer to the pre approval opinions and independent opinions of independent directors on matters related to the 15th meeting of the ninth board of directors disclosed by the company on cninfo.com.
It is hereby announced.
Berry Genomics Co.Ltd(000710) board of directors January 14, 2022 Annex I
Mr. Gao Yang, born in 1980, Chinese nationality, doctoral degree, without permanent residency abroad. Mr. Gao Yang has more than 10 years of experience in R & D and industrialization of gene sequencing industry. Now he is the controlling shareholder and actual controller of the company. He is currently the chairman and general manager of the company and is fully responsible for the company’s strategic planning and operation management. As of the date of this announcement, Mr. Gao Yang holds 40310572 shares of the company, accounting for 11.37% of the total share capital of the company. Ms. Hou Ying, director and deputy general manager of the company, is the person acting in concert with Mr. Gao Yang. Ms. Hou Ying holds 23355661 shares of the company, accounting for 6.59% of the total share capital of the company.
Mr. Gao Yang has no relationship with more than 5% of the shareholders and their actual controllers of other companies except Ms. Hou Ying, other directors, supervisors and senior managers of the company. Mr. Gao Yang has not been punished by the CSRC and other relevant departments or the stock exchange. He is not a dishonest person. His qualification meets the provisions of the company law of the people’s Republic of China and other relevant laws and regulations, There are no circumstances specified in article 3.2.2 of the guidelines for self discipline supervision of listed companies of Shenzhen Stock Exchange No. 1 – standardized operation of listed companies on the main board.
Annex II
Ms. AI Wenlu, born in 1988, Chinese nationality, Bachelor of management, without overseas permanent residency. Ms. AI Wenlu has successively served as Lead Eastern Investment Co.Ltd(000673) securities affairs representative and Secretary of the board of directors. At present, she is the director of investor relations of the company. She has obtained the qualification certificate of secretary of the board of directors and has experience in investor relations management and securities affairs of the company.
As of the date of this announcement, Ms. AI Wenlu, her spouse and other immediate relatives did not directly hold shares of the company. Ms. AI Wenlu has no relationship with the shareholders holding more than 5% of the company and their actual controllers, directors, supervisors and senior managers of the company. She has not been punished by the CSRC and other relevant departments and the stock exchange. She is not a person subject to dishonesty. Her qualifications comply with the provisions of the company law of the people’s Republic of China and other relevant laws and regulations, There are no circumstances specified in article 3.2.2 of the guidelines for self discipline supervision of listed companies of Shenzhen Stock Exchange No. 1 – standardized operation of listed companies on the main board.
